Miro Sciences Ltd. engages in researching and developing biomedical products targeting neurodegenerative conditions. It's research and development program is focused on developing a treatment for stroke-related brain injury and dementia or Alzheimer's disease, and a diagnostic for early-stage Alzheimer's disease. The company was founded by William Harold Clough on November 14, 2002 and is headquartered in Perth, Australia.